About Erik Gatenholm

Erik Gatenholm is a dynamic American entrepreneur who is leveraging his passion for sales, marketing, and lifesciences to create the future of medicine. Gatenholm is the co-founder and CEO of CELLINK – the world’s leading 3D-bioprinting technology company – where he and his team created the first universal bioink in 2016. Today, CELLINK designs state-of-the-art lifescience technologies to support world-renowned research institutions in over 1,900 labs across more than 65 countries. CELLINK’s current customers include esteemed organizations like Harvard, MIT, Johnson & Johnson, Merck and the FDA.

At 28 years old, Gatenholm has been recognized worldwide for his work as an entrepreneur and for the rising success of CELLINK. His tireless spirit quickly distinguished CELLINK in the field and led him to become the face of the entire 3D-bioprinting industry. Honoring his groundbreaking success, prodigious talent and innovative ambitions, Forbes selected Gatenholm among hundreds of thousands of nominees to join the prestigious Forbes 30 Under 30 class of 2018. In addition to this, Gatenholm has been awarded numerous awards such as MIT Review 35 Under 35, Innovator of the Year, Entrepreneur of the Year 2019 and many more. With a growing team of about 200 engineers, scientists and professionals, his mission to change the future of medicine is well on its way to industry disruption.